RackTop Systems, a leading provider of high-performance Software-Defined Storage embedded with advanced security, encryption and compliance, and Network Runners, a top technology consulting services company that serves the commercial and federal government market spaces, today announced they will
MII portfolio company Asclepix Therapeutics raised over $5 million in new funding that will assist in development of new treatment for eye diseases that are leading causes of blindness in adults.
SERAXIS Inc., a rapidly growing regenerative medicine company today announced the publication of important trial considerations for SR-01, its pluripotent stem cell-derived islet therapy for insulin-dependent diabetes.
Longeveron LLC is a regenerative medicine company developing cellular solutions for aging-related diseases. The company is focused on the development of allogeneic (donor-derived) human mesenchymal stem cells (MSCs) that are harvested and grown at its manufacturing facility in Miami, Florida.
Viela Bio was featured this year at the TEDCO Entrepreneur Expo and Stem Cell Symposium as part of a special track on ‘Building Great Companies.’ Their panel discussion, titled ‘Corporate Spinouts: The Viela Bio Story,’ gave attendees a behind-the-scenes look at what went into the company’s launc
Aaron Ren is the head of business development and operations at startup Viela Bio, a MedImmune Inc. spinout. He spoke on a panel at TEDCO's Entrepreneur Expo along with some of the lawyers who worked on the spinout deal.
Celebrating TEDCO's 20th year, the annual Entrepreneur Expo and Stem Cell Symposium focused Thursday on the next steps Maryland should take to realize its potential as a startup ecosystem.
The Shore Hatchery here at Salisbury University has become one of the premiere opportunities for local entrepreneurs and Friday over a dozen were making their pitch in hopes of receiving part of $200,000 in funding.
The program has a focus on supporting women-owned, disadvantaged and rural small businesses. OST Global Solutions' Olessia Smotrova talks about the details, and the SBIR process.
